- Q2 2024 TCM Group A/S Earnings Call TranscriptAug 21, 2024kr64.4 (+1.26%)Earnings
- Q1 2024 TCM Group A/S Earnings Call TranscriptMay 16, 2024kr57 (+8.37%)Earnings
- Q4 2023 TCM Group A/S Earnings Call TranscriptFeb 28, 2024kr50.6 (+2.22%)Earnings
- TCM Group A/S Conference Call TranscriptOct 19, 2023
- Q2 2023 TCM Group A/S Earnings Call TranscriptAug 18, 2023kr62.2 (-3.42%)Earnings
- Q3 2022 TCM Group A/S Earnings Call TranscriptNov 15, 2022kr68.5 (-5.65%)Earnings
- Q2 2022 TCM Group A/S Earnings Call TranscriptAug 19, 2022kr85 (-5.56%)Earnings
- Q1 2022 TCM Group A/S Earnings Call TranscriptMay 18, 2022kr107 (+5.31%)Earnings
- Full Year 2021 TCM Group A/S Earnings Call TranscriptFeb 25, 2022kr124 (+0.40%)Earnings
- Q3 2021 TCM Group A/S Earnings Call TranscriptNov 12, 2021kr158 (-3.07%)Earnings
- Q2 2021 TCM Group A/S Earnings Call TranscriptAug 20, 2021kr158 (+2.60%)Earnings
- Q1 2021 TCM Group A/S Earnings Call TranscriptMay 19, 2021kr164 (-4.93%)Earnings
- Q4 2020 TCM Group A/S Earnings Call TranscriptFeb 24, 2021kr144.5 (-4.30%)Earnings
- Q3 2020 TCM Group A/S Earnings Call TranscriptNov 11, 2020kr128.5 (-4.46%)Earnings
- Q2 2020 Tcm Group A/S Earnings Call TranscriptAug 18, 2020kr129.5 (-5.47%)Earnings
- Q1 2020 Tcm Group A/S Earnings Call TranscriptMay 06, 2020kr94.6 (-1.87%)Earnings
- Q4 2019 Tcm Group A/S Earnings Call TranscriptFeb 26, 2020kr125 (-8.76%)Earnings
- Q3 2019 Tcm Group A/S Earnings Call TranscriptNov 06, 2019kr112 (+0.90%)Earnings
- Q2 2019 Tcm Group A/S Earnings Call TranscriptAug 14, 2019kr112 (+1.36%)Earnings
- Q1 2019 Tcm Group A/S Earnings Call TranscriptMay 07, 2019kr110 (-1.35%)Earnings
Q2 2023 TCM Group A/S Earnings Call Transcript
/-
Good morning, ladies and gentlemen, and welcome to the presentation of Q2 results for TCM Group. Presenters today are our CFO, Thomas Hjannung, and myself, CEO, Torben Paulin. And we will comment on the business and the financial results, after which we will hand over to the operator for the Q&A session.
Let us start the presentation and turn to page 2 for the business update. Sales in Q2 were overall in line with our expectations with a year-on-year decrease of 19%. It should be recalled that Q2 '22 was the strongest quarter ever for the TCM Group in terms of revenue, hence a very strong comparable. B2C sales remained weak in the quarter, confirming that consumers remain cautious. Considering that sales only declined by 3.5% compared to Q1 and that the order intake in the B2B business remained stable in the quarter, we see signs of a potential recovery in the market.
The change in sales mix compared to Q2 last year had a negative impact on gross margin and reduced earnings. However, gross margin improved compared to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)